![]() Atopix Atopix Therapeutics Limited is a privately held, clinical-stage, biopharmaceutical company based in Oxford, UK | ![]() AKESOgen AKESOgen is a biomarker, genomics and pharmacogenomics contract research organization that services the academic, pharmaceutical, biotechnology and agricultural | ||
Founding Date | Founding Date 2012 | Founding Date 2010 | Founding Date 2007 |
Type | Type Private | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Milton, GB HQ | Locations Norcross, US HQ | Locations Cambridge, US HQ |
Employees | Employees N/A | Employees 6 | Employees 324187% increase |
Financial | |||
Revenue (est.) | Revenue (est.) £453.4k (FY, 2017) | Revenue (est.) N/A | Revenue (est.) $236.2m (FY, 2025) |
Net income | Net income £592.1k (FY, 2017) | Net income N/A | Net income ($5.3m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 5.1m | Total funding raised $ 1.5m | Total funding raised N/A |

AKESOgen is a biomarker, genomics and pharmacogenomics contract research organization that services the academic, pharmaceutical, biotechnology and agricultural
View company
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
View company